Clinical Pharmacology of Cefotaxime in Neonates and Infants: Effects and Pharmacokinetics
Clinical Pharmacology of Cefotaxime in Neonates and Infants: Effects and Pharmacokinetics

Gianmaria Pacifici; Giovanna Marchini

Volume 5, Issue 11 , November 2017, , Pages 6111-6138

http://dx.doi.org/10.22038/ijp.2017.26241.2244

Abstract
  Cefotaxime is a bactericidal "third generation" cephalosporin has a broad-spectrum activity against gram-positive microorganisms and exceptional activity against most gram-negative ...  Read More
Clinical Pharmacology of Ceftriaxone in Neonates and Infants: Effects and Pharmacokinetics
Clinical Pharmacology of Ceftriaxone in Neonates and Infants: Effects and Pharmacokinetics

Gian Maria Pacifici; Giovanna Marchini

Volume 5, Issue 9 , September 2017, , Pages 5751-5778

http://dx.doi.org/10.22038/ijp.2017.25371.2155

Abstract
  Ceftriaxone is a versatile and useful "third-generation" cephalosporin that needs to be administered once-daily. Ceftriaxone is a β-lactamase-resistant cephalosporin. It is active ...  Read More
Clinical Pharmacology of Ceftazidime in Neonates: Effects and Pharmacokinetics
Clinical Pharmacology of Ceftazidime in Neonates: Effects and Pharmacokinetics

Gian Maria Pacifici; Giovanna Marchini

Volume 5, Issue 5 , May 2017, , Pages 4803-4819

http://dx.doi.org/10.22038/ijp.2017.22928.1920

Abstract
  Ceftazidime is a valuable third-generation bactericidal cephalosporin. Ceftazidime inhibits the biosynthesis of bacterial cell peptidoglycan, causing inhibition of bacterial growth ...  Read More
Clinical Pharmacology of Cefepime in Infants and Children
Clinical Pharmacology of Cefepime in Infants and Children

Gian Maria Pacifici; Giovanna Marchini

Volume 5, Issue 4 , April 2017, , Pages 4723-4740

http://dx.doi.org/10.22038/ijp.2017.22763.1907

Abstract
  Cefepime is a fourth-generation cephalosporin which is approved in Europe and in the USA. Food and Drug Administration (FDA) approves cefepime in the treatment of febrile neutropenia. ...  Read More
Clinical Pharmacokinetics of Amikacin in Neonates
Clinical Pharmacokinetics of Amikacin in Neonates

Gian Maria Pacifici; Giovanna Marchini

Volume 5, Issue 2 , February 2017, , Pages 4407-4428

http://dx.doi.org/10.22038/ijp.2017.21706.1815

Abstract
  Amikacin is a bactericidal aminoglycoside. Aminoglycosides inhibit bacterial protein synthesis. The antibacterial spectrum of amikacin is the broadest of aminoglycosides. Because of ...  Read More